Sander van Deventer MD, PhD
Operating Partner
Cardiovascular therapeutic
Staten Biotechnology aims to develop novel and innovative strategies for the treatment of dyslipidemia.
Human Health
NL
Transistorweg 5J
6534 AT Nijmegen
Industry
Biotech
Status
Past
Location
The Netherlands
Forbion team